Control of endemic MRSA - what is the evidence? A personal view

被引:51
作者
Marshall, C
Wesselingh, S
McDonald, M
Spelman, D
机构
[1] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia
[2] Alfred Hosp, Infect Control & Hosp Epidemiol Unit, Melbourne, Vic, Australia
[3] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia
[4] Menzies Sch Hlth Res, Darwin, NT, Australia
[5] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia
关键词
methicillin-resistant; Staphylococcus aureus; MRSA; infection control; endemic; epidemic; evidence;
D O I
10.1016/j.jhin.2004.02.001
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Although there is extensive literature on the control of MRSA, when that concerning epidemics is excluded, only a limited amount remains regarding the control of endemic MRSA. Several guidelines have been recently published recommending stringent control measures, which are often suggested based on their success in controlling MRSA outbreaks in hospitals with few MRSA or in containing MRSA cases introduced into a hospital with no MRSA. In these settings, multiple measures are usually introduced with apparently successful results. However, results may not be generalizable to other settings and we do not know the minimum effective measures required for MRSA containment. This paper aims critically to review the literature to determine whether evidence exists for the value of the infection control measures that are widely recommended in the endemic setting. Much of this literature is based on observational studies, with few randomized, controlled trials having been conducted. More well-designed studies are required before many of the principles on which we build infection control programmes can be regarded as evidence based. (C) 2004 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:253 / 268
页数:16
相关论文
共 171 条
[61]   Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus [J].
Harbarth, S ;
Dharan, S ;
Liassine, N ;
Herrault, P ;
Auckenthaler, R ;
Pittet, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) :1412-1416
[62]   Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus [J].
Harbarth, S ;
Martin, Y ;
Rohner, P ;
Henry, N ;
Auckenthaler, R ;
Pittet, D .
JOURNAL OF HOSPITAL INFECTION, 2000, 46 (01) :43-49
[63]  
HARTSTEIN AI, 1995, INFECT CONT HOSP EP, V16, P405
[64]  
Hartstein AI, 1997, INFECT CONT HOSP EP, V18, P42
[65]   A COMPARISON OF CLINICAL VIRULENCE OF NOSOCOMIALLY ACQUIRED METHICILLIN-RESISTANT AND METHICILLIN-SENSITIVE STAPHYLOCOCCUS-AUREUS INFECTIONS IN A UNIVERSITY HOSPITAL [J].
HERSHOW, RC ;
KHAYR, WF ;
SMITH, NL .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1992, 13 (10) :587-593
[66]  
HERWALDT LA, 1999, AM J MED, V106, P11, DOI DOI 10.1016/S0002-9343(98)00350-7
[67]   The emergence and evolution of methicillin-resistant Staphylococcus aureus [J].
Hiramatsu, K ;
Cui, L ;
Kuroda, M ;
Ito, T .
TRENDS IN MICROBIOLOGY, 2001, 9 (10) :486-493
[68]  
HIRAMATSU K, 1997, MMWR-MORBID MORTAL W, V46, P624
[69]   Carriage of methicillin-resistant Staphylococcus aureus, ceftazidime-resistant Gram-negative bacilli, and vancomycin-resistant enterococci before and after intensive care unit admission [J].
Ho, PL .
CRITICAL CARE MEDICINE, 2003, 31 (04) :1175-1182
[70]   Clonal analysis and identification of epidemic strains of methicillin-resistant Staphylococcus aureus by antibiotyping and determination of protein A gene and coagulase gene polymorphisms [J].
HoefnagelsSchuermans, A ;
Peetermans, WE ;
Struelens, MJ ;
VanLierde, S ;
VanEldere, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (10) :2514-2520